Teva sues five companies for alleged Copaxone infringement

14-04-2015

Teva sues five companies for alleged Copaxone infringement

Photo: Tevapharm.com

Israeli pharmaceutical company Teva has, in one single filing, accused five generic drug makers of infringing a patent covering its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).


Teva, Copaxone, Mylan, Dr. Reddy’s, patent infringement, US District Court for the District of Delaware

LSIPR